Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)Matthew M.Y. Lee, Naveed Sattar, Katriona Brooksbank et al.|Circulation|2020Cited by 437
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney diseaseJennifer S. Lees, Patrick B. Mark, Claire Welsh et al.|Nature Medicine|2019Cited by 312
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysisPeter Willeit, Mary Cushman, Michael Hecht Olsen et al.|The Lancet Diabetes & Endocrinology|2016Cited by 224
Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular DiseaseClaire Welsh, Paul Welsh, Carlos Celis‐Morales et al.|Circulation|2019Cited by 200
Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma LevelsMaria Sabater‐Lleal, Mary Cushman, Jennifer E. Huffman et al.|Circulation|2019Cited by 170